Effects of Montreal Museum of Fine Arts Visits and Older Community Dwellers With a Precarious State
NCT ID: NCT03962985
Last Updated: 2024-07-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
41 participants
INTERVENTIONAL
2019-07-23
2024-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A 3-month Cycle of Weekly Montreal Museum of Fine Arts Tours
NCT04298047
Virtual Guided Tour of the MMFA for Prevention of Social Isolation
NCT05046288
A 3-month Cycle of Virtual Guided Tours to Promote Health in Older Community Members in a Context of COVID-19 Induced Social Isolation: a Pilot Study
NCT04593433
Museum Prescription by a Physician for a Visit to the MBAM
NCT05445453
Geriatric Inclusive Art: Effects of Painting Sessions on Older In-patients With Cognitive Decline
NCT03624387
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
The 41 participants will attend the guided tours at the Montreal Museum of Fine Arts.
Guided tour at the Montreal Museum of Fine Arts
* The duration of the participation -3 months
* The duration of the guided tour-45 minutes, each week
* All participants will be asked to fill out some specific online questionnaires during their participations in the study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Guided tour at the Montreal Museum of Fine Arts
* The duration of the participation -3 months
* The duration of the guided tour-45 minutes, each week
* All participants will be asked to fill out some specific online questionnaires during their participations in the study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Precarious condition defined with a score ≥30 (/100)
* Having an Internet access with an electronic device (i.e.; laptop, computer, smartphone, tablet) as the repetitive assessments for this study will be performed on the web platform of the Centre of Excellence on Longevity of McGill University;
* Understanding and writing the different languages of the recruitment centre (i.e., French, English, Chinese.);
* Severe frail condition determined with the Centre of Excellence self-administered questionnaire (CESAM)
* Living in Montreal
Exclusion Criteria
* Participation in another art-based activity;
* Palliative care;
* Living in residence;
* Having a moderate to severe mobility impairment (i.e. using a walker, a wheelchair or being unable to walk alone 10m).
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jewish General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Olivier Beauchet
MD, Professor of Geriatrics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Olivier Beauchet, MD
Role: PRINCIPAL_INVESTIGATOR
Jewish General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jewish General Hospital
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-1789
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.